Jinliang Peng
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery 7
- Rehabilitation top 1%
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics 7
- Graphene and Nanomaterials Applications 5
- Bone Tissue Engineering Materials 5
- Molecular Medicine top 5%
- Pharmaceutical Science top 5%
-
- RNA Interference and Gene Delivery 13
- Advanced biosensing and bioanalysis techniques 7
-
- Immunotherapy and Immune Responses 7
-
- Microbial Inactivation Methods 5
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Jinliang Peng
51 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 126
- Biomaterials 871
- Rehabilitation 335
- Biomedical Engineering 1.1k
- Molecular Medicine 120
- Pharmaceutical Science 69
Countries citing papers authored by Jinliang Peng
This map shows the geographic impact of Jinliang Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinliang Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinliang Peng more than expected).
Fields of papers citing papers by Jinliang Peng
This network shows the impact of papers produced by Jinliang Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinliang Peng. The network helps show where Jinliang Peng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jinliang Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 15 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 4 | |
| 9 | 2022 | 87 | |
| 10 | 2020 | 1 | |
| 11 | 2020 | 1 | |
| 12 | 2020 | 5 | |
| 13 | 2019 | 22 | |
| 14 | 2017 | 39 | |
| 15 | 2015 | 19 | |
| 16 | 2013 | 394 | |
| 17 | 2010 | 92 | |
| 18 | 2006 | 23 | |
| 19 | 2005 | 36 | |
| 20 | Study on the toxicological response of Chlorella to anthracene under different nutrient conditions | 1999 | 1 |
About Jinliang Peng
Jinliang Peng is a scholar working on Biomaterials, Rehabilitation and Biotechnology, having authored 55 papers that have together received 2.6k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (13 papers), Nanoparticle-Based Drug Delivery (7 papers), Immunotherapy and Immune Responses (7 papers), Nanoplatforms for cancer theranostics (7 papers), Advanced biosensing and bioanalysis techniques (7 papers), Graphene and Nanomaterials Applications (5 papers), Bone Tissue Engineering Materials (5 papers) and Microbial Inactivation Methods (5 papers). The work is most often cited by research in Biomaterials (871 citations), Rehabilitation (335 citations) and Biomedical Engineering (1.1k citations). Jinliang Peng has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Yuhong Xu, Jiang Chang, Maoquan Chu, Yuxiang Shao, Haiyan Li, Yan Han, Donglu Shi, Qingsheng Wu, Haikuo Li and Shuxian Song. Their work appears in journals such as ACS Nano, PLoS ONE and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.